Repligen Corp. (RGEN)
181.69
+0.56
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
181.69
0.00 (0.00%)
After-Hours: 20:00
Repligen Net Income (Quarterly) : 5.008M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.008M |
| March 31, 2026 | 8.333M |
| December 31, 2025 | 13.29M |
| September 30, 2025 | 14.91M |
| June 30, 2025 | 14.87M |
| March 31, 2025 | 5.83M |
| December 31, 2024 | -33.87M |
| September 30, 2024 | -0.654M |
| June 30, 2024 | 5.713M |
| March 31, 2024 | 3.296M |
| December 31, 2023 | -16.45M |
| September 30, 2023 | 16.92M |
| June 30, 2023 | 19.79M |
| March 31, 2023 | 15.34M |
| December 31, 2022 | 48.73M |
| September 30, 2022 | 40.40M |
| June 30, 2022 | 49.86M |
| March 31, 2022 | 46.96M |
| December 31, 2021 | 29.11M |
| September 30, 2021 | 33.50M |
| June 30, 2021 | 36.23M |
| March 31, 2021 | 29.45M |
| December 31, 2020 | 19.70M |
| September 30, 2020 | 14.55M |
| June 30, 2020 | 15.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.815M |
| December 31, 2019 | 3.604M |
| September 30, 2019 | 1.659M |
| June 30, 2019 | 8.095M |
| March 31, 2019 | 8.053M |
| December 31, 2018 | 5.638M |
| September 30, 2018 | 4.794M |
| June 30, 2018 | 2.738M |
| March 31, 2018 | 3.448M |
| December 31, 2017 | 12.18M |
| September 30, 2017 | 4.669M |
| June 30, 2017 | 8.438M |
| March 31, 2017 | 3.068M |
| December 31, 2016 | 5.029M |
| September 30, 2016 | 1.155M |
| June 30, 2016 | 3.872M |
| March 31, 2016 | 1.625M |
| December 31, 2015 | 0.265M |
| September 30, 2015 | 2.538M |
| June 30, 2015 | 3.613M |
| March 31, 2015 | 2.930M |
| December 31, 2014 | -0.398M |
| September 30, 2014 | 1.466M |
| June 30, 2014 | 2.825M |
| March 31, 2014 | 4.277M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 45.10M |
| Danaher Corp. | 870.00M |
| Liquidia Corp. | 74.72M |
| Harmony Biosciences Holdings, Inc. | 75.43M |
| Agilent Technologies, Inc. | 339.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 204.13M |
| Total Expenses (Quarterly) | 199.12M |
| EPS Diluted (Quarterly) | 0.0884 |
| Enterprise Value | 10.10B |
| Gross Profit Margin (Quarterly) | 49.25% |
| Profit Margin (Quarterly) | 2.45% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 0.69% |
| Normalized Earnings Yield | 0.4492 |